2,4,5,2',4',5'-hexabromobiphenyl has been researched along with Cardiometabolic Syndrome in 1 studies
*Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Che, Z; Chen, R; Fan, Z; Jia, H; Pan, K; Su, C; Wu, Z; Zhang, T | 1 |
1 other study(ies) available for 2,4,5,2',4',5'-hexabromobiphenyl and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Associations between exposure to brominated flame retardants and metabolic syndrome and its components in U.S. adults.
Topics: Adult; Bayes Theorem; Environmental Exposure; Female; Flame Retardants; Humans; Hydrocarbons, Brominated; Hypertriglyceridemia; Male; Metabolic Syndrome; Nutrition Surveys; Obesity; Obesity, Abdominal; Prospective Studies | 2023 |